作者: Thomas D. Wang , Bishnu P. Joshi
DOI:
关键词: Cancer research 、 Dysplasia 、 Cancer cell 、 Peptide 、 Cancer 、 Early cancer 、 Medicine
摘要: The present disclosure is directed to HER2-specific peptide reagents, methods for detecting pre-cancer (dysplasia), early cancer and/or using the and targeting pre-cancerous (dysplastic) cells, cells reagents.